Mangalam Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE584F01014
  • NSEID: MANGALAM
  • BSEID: 532637
INR
30.69
0.6 (1.99%)
BSENSE

May 08

BSE+NSE Vol: 59.28 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.69",
    "chg": 0.6,
    "chgp": "1.99%",
    "dir": 1,
    "prev_price": "30.09",
    "mcapval": "48.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE584F01014",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "59.28 k",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Mangalam Drugs and Organics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-mangalam-drugs-and-organics-ltd-3980424",
        "imagepath": "",
        "date": "2026-05-07 23:16:40",
        "description": "The next results date for Mangalam Drugs and Organics Ltd is scheduled for 14 May 2026...."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3964269",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MangalamDrugsan_mojoScore_3964269.png",
        "date": "2026-04-27 10:10:25",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3944648",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MangalamDrugsan_mojoScore_3944648.png",
        "date": "2026-04-13 10:10:14",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 13 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3937245",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MangalamDrugsan_stocks_hitting_upper_circuit_3937245.png",
        "date": "2026-04-08 10:00:08",
        "description": "At Rs 31.57, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 4.99% on 8 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Mangalam Drugs Gains 2.29%: Circuit Limits Highlight Volatility and Investor Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-gains-229-circuit-limits-highlight-volatility-and-investor-sentiment-3933465",
        "imagepath": "",
        "date": "2026-04-05 16:00:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>30 Mar:</strong> Lower circuit hit amid heavy selling pressure (₹27.05)</p>\n                    <p><strong>1 Apr:</strong> Upper circuit hit on strong buying interest (₹28.05)</p>\n                    <p><strong>2 Apr:</strong> Marginal gain with subdued volume (₹29.06)</p>\n                    <p><strong>3 Apr:</strong> Week closes at ₹29.06, up 2.29% vs Sensex down 0.29%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.27.74</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.29.06</div..."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-3930208",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MangalamDrugsan_mojoScore_3930208.png",
        "date": "2026-04-02 10:10:16",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-3928514",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MangalamDrugsan_stocks_hitting_upper_circuit_3928514.png",
        "date": "2026-04-01 10:00:09",
        "description": "At Rs 28.50, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 5% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Lower Circuit With 4.92% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-lower-circuit-amid-heavy-selling-pressure-3925512",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MangalamDrugsan_stocks_hitting_lower_circuit_3925512.png",
        "date": "2026-03-30 15:00:05",
        "description": "At Rs 27.05, sellers were still queuing — but there were no buyers willing to take the other side. Mangalam Drugs and Organics Ltd locked at its lower circuit of 4.92% on 30 Mar 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity."
      },
      {
        "title": "Mangalam Drugs Falls 4.60%: Circuit Hits and Volatility Define the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-falls-460-circuit-hits-and-volatility-define-the-week-3922325",
        "imagepath": "",
        "date": "2026-03-28 17:05:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>23 Mar:</strong> Stock declines 1.41% amid broad market sell-off</p>\n                    <p><strong>24 Mar:</strong> Hits upper circuit at Rs.30.29, surging 4.16%</p>\n                    <p><strong>25 Mar:</strong> Recovers modestly, closing flat at Rs.29.36 (+1.14%)</p>\n                    <p><strong>27 Mar:</strong> Plunges to lower circuit, closing at Rs.28.41 (-3.24%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.29.78</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.28.41</di..."
      }
    ],
    "total": 192,
    "sid": "138636",
    "stock_news_url": "https://www.marketsmojo.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th May 2026 Inter-Alia To Approve Audited Financial Results(Standalone & Consolidated) Of The Company For The Period Ended 31St March 2026",
      "datetime": "06-May-2026",
      "details": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Intimation of Board meeting to be held on 14th May 2026 inter-alia to approve Audited Financial results (Standalone & Consolidated)of the Company for the period ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "29-Apr-2026",
      "details": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on April 29 2026 for Shree Kishoriju Trading and Investments Pvt Ltd",
      "source": "BSE"
    },
    {
      "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "29-Apr-2026",
      "details": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on April 29 2026 for Aditya Ramniwas Dhoot",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 May 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Mangalam Drugs Gains 2.29%: Circuit Limits Highlight Volatility and Investor Sentiment

2026-04-05 16:00:42

Key Events This Week

30 Mar: Lower circuit hit amid heavy selling pressure (₹27.05)

1 Apr: Upper circuit hit on strong buying interest (₹28.05)

2 Apr: Marginal gain with subdued volume (₹29.06)

3 Apr: Week closes at ₹29.06, up 2.29% vs Sensex down 0.29%

stock-recommendationAnnouncement

Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 14Th May 2026 Inter-Alia To Approve Audited Financial Results(Standalone & Consolidated) Of The Company For The Period Ended 31St March 2026

06-May-2026 | Source : BSE

Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 inter alia to consider and approve Intimation of Board meeting to be held on 14th May 2026 inter-alia to approve Audited Financial results (Standalone & Consolidated)of the Company for the period ended 31st March 2026

Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

29-Apr-2026 | Source : BSE

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on April 29 2026 for Shree Kishoriju Trading and Investments Pvt Ltd

Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

29-Apr-2026 | Source : BSE

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on April 29 2026 for Aditya Ramniwas Dhoot

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

14 May 2026

stock-summary
DIVIDEND

Mangalam Drugs and Organics Ltd has declared 5% dividend, ex-date: 21 Dec 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available